Comparative study of mupirocin and sodium fucidate in the prophylaxis of exit-site infections in CAPD patients.
Danguilan
Romina A
RA
Department of Nephrology, National Kidney and Transplant Institute, Quezon City, Philippines. rad@skyinet.net
Evangelista
Liezl P
LP
Abrenica
Mildred S
MS
Rondilla
Stella Marie S
SM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D002404:Catheterization / Q000009:adverse effects; D005500:Follow-Up Studies; D005672:Fusidic Acid / Q000627:therapeutic use*; D006801:Humans; D016712:Mupirocin / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000295:instrumentation
D000900:Anti-Bacterial Agents; D005672:Fusidic Acid; D016712:Mupirocin